Yu Waye Chu
Chief Tech/Sci/R&D Officer bei CYTOMX THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Yu Waye Chu hat die Position des Senior Vice President-Clinical Development bei Fate Therapeutics, Inc. inne. Er erhielt einen Undergraduate-Abschluss von der Princeton University und einen Doktortitel von der University of Rochester School of Medicine & Dentistry.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FATE THERAPEUTICS, INC.
0,14% | 18.04.2023 | 140 676 ( 0,14% ) | 1 Mio $ | 31.03.2024 |
| 18.01.2024 | 26 250 ( 0,04% ) | 57 225 $ | 31.03.2024 |
Aktive Positionen von Yu Waye Chu
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17.07.2023 |
Ehemalige bekannte Positionen von Yu Waye Chu
| Unternehmen | Position | Ende |
|---|---|---|
| FATE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 14.07.2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.04.2019 |
Ausbildung von Yu Waye Chu
| Princeton University | Undergraduate Degree |
| University of Rochester School of Medicine & Dentistry | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
